Literature DB >> 8912483

Atrophy of the corpus callosum associated with cognitive impairment and widespread cortical hypometabolism in carotid artery occlusive disease.

H Yamauchi1, H Fukuyama, Y Nagahama, Y Katsumi, Y Dong, J Konishi, J Kimura.   

Abstract

OBJECTIVE: To investigate whether atrophy of the corpus callosum is associated with cognitive impairment and widespread cerebral cortical hypometabolism in carotid artery occlusive disease. PATIENTS: Twelve patients with unilateral internal carotid artery occlusive disease (1 with severe stenosis and 11 with occlusion) and no cortical infarction in the chronic stage (mean +/- SD age, 64 +/- 5 years). MAIN OUTCOME MEASURES: Midsagittal corpus callosum area-skull area ratio (on T1-weighted magnetic resonance images), the sum of the scaled scores of the 6 subtests on the Wechsler Adult Intelligence Scale-Revised (Digit Span, Arithmetic, Picture Arrangement, Object Assembly, Block Design, and Digit Symbol), and cerebral metabolic rate of oxygen (measured with position emission tomography by using the oxygen 15 steady-state technique).
RESULTS: The degree of cognitive impairment varied but was strongly correlated with the severity of callosal atrophy (r = 0.92, P < .001). Patients with callosal atrophy and cognitive decline also showed decreased oxygen consumption in the bilateral cerebral cortices. Stepwise regression analysis revealed that the severity of white matter lesions, especially in the centrum semiovale, and that of cortical atrophy in the hemisphere with arterial disease were 2 important factors for callosal atrophy.
CONCLUSIONS: Callosal atrophy is associated with cognitive impairment and widespread cerebral cortical hypometabolism in carotid artery occlusive disease without cortical infarction. Callosal atrophy might reflect the severity of the disconnection between cortical regions, and this may be an important factor in the development of cognitive impairment with widespread cortical hypometabolism in carotid artery occlusive disease without large cortical lesions.

Entities:  

Mesh:

Year:  1996        PMID: 8912483     DOI: 10.1001/archneur.1996.00550110039011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

1.  An electrophysiological investigation of interhemispheric transfer time in children and adolescents with high-functioning autism spectrum disorders.

Authors:  Ann Clawson; Peter E Clayson; Mikle South; Erin D Bigler; Michael J Larson
Journal:  J Autism Dev Disord       Date:  2015-02

2.  Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases.

Authors:  H Yamauchi; H Fukuyama; Y Dong; H Nabatame; Y Nagahama; S Nishizawa; J Konishi; H Shio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-03       Impact factor: 10.154

3.  Selective neuronal damage and Wisconsin Card Sorting Test performance in atherosclerotic occlusive disease of the major cerebral artery.

Authors:  Hiroshi Yamauchi; Ryuichi Nishii; Tatsuya Higashi; Shinya Kagawa; Hidenao Fukuyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-08-27       Impact factor: 10.154

Review 4.  Is Hemispheric Hypoperfusion a Treatable Cause of Cognitive Impairment?

Authors:  Amani M Norling; Randolph S Marshall; Marykay A Pavol; George Howard; Virginia Howard; David Liebeskind; John Huston; Brajesh K Lal; Thomas G Brott; Ronald M Lazar
Journal:  Curr Cardiol Rep       Date:  2019-01-19       Impact factor: 2.931

5.  Long-term effects of cerebral hypoperfusion on neural density and function using misery perfusion animal model.

Authors:  Asuka Nishino; Yosuke Tajima; Hiroyuki Takuwa; Kazuto Masamoto; Junko Taniguchi; Hidekatsu Wakizaka; Daisuke Kokuryo; Takuya Urushihata; Ichio Aoki; Iwao Kanno; Yutaka Tomita; Norihiro Suzuki; Yoko Ikoma; Hiroshi Ito
Journal:  Sci Rep       Date:  2016-04-27       Impact factor: 4.379

Review 6.  Selective neuronal loss in ischemic stroke and cerebrovascular disease.

Authors:  Jean-Claude Baron; Hiroshi Yamauchi; Masayuki Fujioka; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-06       Impact factor: 6.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.